CD14 and hereditary angioedema: During the attack, patients with HAE presented higher expression of BR2 on the HLA-DR+CD14+ (80.04%; 57.90–97.95%) comparing to remission state (76.58%; 34.65–95.69%; p = 0.386) and healthy subjects (64.29%; 40.26–94.50%; p = 0.0189).